CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Relaxis
Relaxis logo

Relaxis

Relaxis, a pioneer in RLS treatment, develops unique vibratory counterstimulation devices to improve sleep quality for RLS patients.

San Clemente, CA, US🇺🇸
Founded
2009
Overview
Compare
Fundraising
Employees

Relaxis is a pioneer in developing medical devices for restless legs syndrome (RLS). Their core mission is to enhance sleep quality for RLS patients through vibratory counterstimulation. The company offers the first and only device specifically indicated to improve sleep in primary RLS patients by using vibration to counteract unpleasant sensations.

Relaxis has made significant strides in the medical device industry, providing a unique solution for a condition that affects many individuals. Their innovative approach has positioned them as a leader in RLS treatment, significantly impacting patient well-being.

Relaxis - Similar Companies

TranquilMed logo

TranquilMed

Realeve logo

Realeve

Reliefband Technologies logo

Reliefband Technologies

reliefband.com

Ulevo Health logo

Ulevo Health

ulevohealth.com

Invicta Medical logo

Invicta Medical

Vital Motion logo

Vital Motion

vitalmotion.com

Ensr Medical logo

Ensr Medical

GoRelax logo

GoRelax

gorelax.co

Noctrix Health logo

Noctrix Health

noctrixhealth.com

Relavo logo

Relavo

relavomedical.com

Relievant Medsystems logo

Relievant Medsystems

relievant.com

Tanzen Medical logo

Tanzen Medical

tanzenmed.com

RBI Medical logo

RBI Medical

Birch Tree Medical logo

Birch Tree Medical

RxFunction logo

RxFunction

rxfunction.com

Relaxis - Quick Facts

Who are Relaxis' competitors?

Companies similar to Relaxis include TranquilMed, Realeve, Reliefband Technologies and Ulevo Health.

When was Relaxis founded?

Relaxis was founded in 2009.

Where is Relaxis' headquarters located?

Relaxis' headquarters is located in San Clemente, CA, US.

When was Relaxis' last funding round?

Relaxis' most recent funding round was for $1.5M (USD) in January 2015.

How much disclosed funding has Relaxis raised?

As of Jan 14, 2015, Relaxis has disclosed funding of $10.5M (USD). Undisclosed round amounts are excluded.

How many employees does Relaxis have?

Relaxis has 30 employees as of Feb 4, 2024.

Relaxis - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture-backed
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified